Drupal.behaviors.print = function(context) {window.print();window.close();}>
Pathwork's Economics Study Finds TOO Test 'Strongly' Cost-Effective in Extending Survival
January 18, 2012
Pathwork's Economics Study Finds TOO Test 'Strongly' Cost-Effective in Extending Survival
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Prospective Study Suggests Site-Specific Treatment after BioTheranostics' CUP Testing Improves Survival
October 17, 2012 / Pharmacogenomics Reporter
Canadian Team Says Four-Gene Signature Could Predict Oral Cancer Recurrence, Improve on Histology
October 19, 2011 / Pharmacogenomics Reporter
Pathwork Diagnostics Gets CAP Accreditation
March 28, 2011 / GenomeWeb Daily News
FDA Clears Pathwork Diagnostics' Tissue-of-Origin Test for Use with FFPE Samples
June 15, 2010 / BioArray News
Researchers ID Colorectal Cancer Subtypes through Expression Profiling; Prognostic Value Noted
May 22, 2013 / GenomeWeb Daily News